CD44 on cancer stem cell is a potential immunological and prognostic pan-cancer biomarker
CD44 is both a cancer stem cell marker and a potential prognostic and immunological biomarker in various malignant tumors. Moreover, CD44 could be a novel target for immune-based therapy.
Authors
- Shan-Shan Yang
- Zhuoyuan Zhang (ORCID: https://orcid.org/0000-0003-4324-1712)
- Siying Li (ORCID: https://orcid.org/0000-0001-6906-8394)
- Jiyan Liu (ORCID: https://orcid.org/0000-0003-4885-5481)
- Yajuan Zhu (ORCID: https://orcid.org/0009-0005-0161-2433)
- Yang Du (ORCID: https://orcid.org/0009-0005-9825-6040)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- State Key Laboratory of Biotherapy
Publication Details
- Journal
- Cancer Cell International
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1186/s12935-025-03748-4
- Citations
- 8
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 8.36
Funders
- National Natural Science Foundation of China